Kheiron, based in London, aims to revolutionize cancer detection and treatment through advanced AI technologies. By focusing on B2B solutions, Kheiron collaborates with healthcare providers to enhance diagnostic accuracy and treatment efficacy, reducing missed diagnoses and delayed treatments. With backing from prominent venture capital firms, Kheiron has strong financial support to innovate and scale its offerings. Their advanced methods position them favorably against traditional diagnostic practices, making them a promising player in health tech.